original ) (raw )A Comparison of Once-Daily Extended-Release Methylphenidate Formulations in Children With Attention-Deficit/Hyperactivity Disorder in the Laboratory School (The Comacs Study)
James Swanson
PEDIATRICS, 2004
View PDFchevron_right
Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies
Alessandro Zuddas
BMC Psychiatry, 2013
View PDFchevron_right
Methylphenidate extended-release oral suspension for the treatment of attention-deficit/hyperactivity disorder: a practical guide for pharmacists
Edress Darsey
Integrated Pharmacy Research and Practice
View PDFchevron_right
Titrating Optimal Dose of Osmotic-Controlled Release Oral Delivery (OROS)-Methylphenidate and Its Efficacy and Safety in Korean Children with ADHD: A Multisite Open Labeled Study
Soul Choi
Psychiatry Investigation, 2012
View PDFchevron_right
Preferences for Attention-Deficit/Hyperactivity Disorder (ADHD) Non-Stimulant Treatment Characteristics Among Children and Adolescents With ADHD and Their Caregivers
Frank Lopez
Journal of Health Economics and Outcomes Research, 2016
View PDFchevron_right
Remission in Children and Adolescents Diagnosed with Attention-Deficit/Hyperactivity Disorder via an Effective and Tolerable Titration Scheme for Osmotic Release Oral System Methylphenidate
Yu-shu Huang
Journal of Child and Adolescent Psychopharmacology, 2012
View PDFchevron_right
A randomized, controlled effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention deficit-hyperactivity disorder
Margaret D Weiss
The Canadian Journal of Clinical Pharmacology Journal Canadien De Pharmacologie Clinique, 2006
View PDFchevron_right
Switching from immediate- to sustained-release psychostimulants in routine treatment of children with attention-deficit hyperactivity disorder
saeed nazir
Psychiatric Bulletin, 2006
View PDFchevron_right
Efficacy and Safety of Dexmethylphenidate Extended-Release Capsules In Children With Attention-Deficit/Hyperactivity Disorder
Rafael Muniz
Journal of the American …, 2006
View PDFchevron_right
Individualizing the dosage of Methylphenidate in children with attention deficit hyperactivity disorder
Javad Mahmoudi-gharaei
BMC Medical Research Methodology, 2020
View PDFchevron_right
Efficacy and Safety of Immediate-Release Methylphenidate Treatment for Preschoolers With ADHD
James McCracken , B. Vitiello , Howard Abikoff
Journal of the American Academy of Child & Adolescent Psychiatry, 2006
View PDFchevron_right
Long-Acting Methylphenidate-OROS in Youths with Attention-Deficit Hyperactivity Disorder Suboptimally??Controlled with Immediate-Release Methylphenidate
Luuk Kalverdijk
CNS Drugs, 2008
View PDFchevron_right
Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: A multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials
Howard Abikoff
Clinical Therapeutics, 2009
View PDFchevron_right
Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder
John Orazem
Journal of Child and Adolescent Psychopharmacology
View PDFchevron_right
A Double-Blind, Placebo-Controlled Study of Modified-Release Methylphenidate in Children With Attention-Deficit/Hyperactivity Disorder
James Swanson
PEDIATRICS, 2002
View PDFchevron_right
Efficacy and Safety of Dexmethylphenidate Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder
Frank Lopez
Biological Psychiatry, 2007
View PDFchevron_right
Long-Term Efficacy of Methylphenidate Immediate-Release for the Treatment of Childhood ADHD: A Systematic Review and Meta-Analysis
Carisi Polanczyk
Journal of attention disorders, 2014
View PDFchevron_right
Stimulant formulations for the treatment of ADHD
Mohan Gautam
2019
View PDFchevron_right
Efficacy and Safety of a Long-Acting Multilayer-Release Methylphenidate Formulation (PRC-063) in the Treatment of Adolescent Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Clinical Trial with a 6-Month Open-Label Extension
Margaret D Weiss
Journal of Child and Adolescent Psychopharmacology
View PDFchevron_right
Parents’ Decision Regarding the Use of Medication Treatment to Control their Children’s Hyperactivity
Shewikar Farrag
Research in Pediatrics & Neonatology, 2017
View PDFchevron_right
Heterogeneity in the pharmacodynamics of two long-acting methylphenidate formulations for children with attention deficit/hyperactivity disorder
Pol Van Lier
European Child & Adolescent Psychiatry, 2008
View PDFchevron_right
Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulants
Richard Weisler
European Child & Adolescent Psychiatry, 2010
View PDFchevron_right
An observational study of once-daily modified-release methylphenidate in ADHD: effectiveness on symptoms and impairment, and safety
Tin Hung Wong
View PDFchevron_right
Methylphenidate Dosage for Children With ADHD Over Time Under Controlled Conditions: Lessons From the MTA
John March
Journal of The American Academy of Child and Adolescent Psychiatry, 2001
View PDFchevron_right
Parents’ Decision Regarding the Use of Medication Treatment to Control their Children’s Hyperactivity-Crimson Publishers
Shewikar Farrag , Research in Pediatrics & Neonatology
View PDFchevron_right
Methylphenidate Hydrochloride Modified-Release in Adults with Attention Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Trial
vinod kumar
Advances in Therapy, 2014
View PDFchevron_right
Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder
Rossella Medori
Neuropsychiatric disease and treatment, 2009
View PDFchevron_right
Development of a New Once-a-Day Formulation of Methylphenidate for the Treatment of Attention-deficit/Hyperactivity Disorder
Suneel Gupta
Archives of General Psychiatry, 2003
View PDFchevron_right
Randomized, Controlled Trial of OROS Methylphenidate Once a Day in Children With Attention-Deficit/Hyperactivity Disorder
Marc Atkins
2000
View PDFchevron_right